Analyst Research

Report Title Price
Provider: Directors Deals Ltd.
Provider: GlobalData
Provider: Thomson Reuters Stock Report
Provider: Peel Hunt

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Immunodiagnostic Systems Holdings PLC Issues FY 2014 Guidance In Line With Analysts' Estimates

Thursday, 10 Oct 2013 02:00am EDT 

Immunodiagnostic Systems Holdings PLC announced that it anticipate that revenues for fiscal 2014 will show modest growth year on year, with pre-exceptional profit in line with the prior financial year. The Company reported revenue of GBP49.77 million and net income of GBP7.61 million in fiscal 2013. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of GBP51.00 million and net income of GBP7.71 million for fiscal 2014. 

Company Quote

0.0 +0.00%
19 Dec 2014